文献速递牙体牙髓病

预冷麻醉剂与增加剂量对阿替卡因下颌第一磨牙症状性不可逆性牙髓炎下牙槽神经阻滞成功率影响的比较:一项双盲随机对照临床试验

Effect of Precooling the Anesthetic Agent in Comparison to Increasing the Dosage on the Success Rate of Inferior Alveolar Nerve Block Using Articaine in Mandibular First Molars with Symptomatic Irreversible Pulpitis: A Double-Blind, Randomized, Controlled Clinical Trial.
PubMed 文献 · J Endod · 2025-05-28

该双盲随机对照试验纳入90颗症状性不可逆性牙髓炎的下颌第一磨牙,比较常规1.8 mL阿替卡因、3.6 mL阿替卡因及4°C预冷1.8 mL阿替卡因行下牙槽神经阻滞的疗效。结果显示2C组与CC组疼痛水平无显著差异,但均显著低于1C组;结论认为冷阿替卡因较室温阿替卡因显著提高阻滞成功率,而增加剂量亦显著提高成功率。

要点

  • 预冷阿替卡因与增加剂量均可提高症状性不可逆性牙髓炎下颌第一磨牙下牙槽神经阻滞成功率。
  • 2C组与CC组疼痛水平无显著差异(P > .05)。
  • 1C组与2C组、1C组与CC组疼痛水平差异显著(P < .05)。

核心结论

  • 与室温阿替卡因下牙槽神经阻滞相比,使用冷阿替卡因可显著提高症状性不可逆性牙髓炎下颌第一磨牙下牙槽神经阻滞的成功率;增加阿替卡因剂量亦带来显著更高的成功率。

研究设计与样本

  • 随机双盲临床试验,纳入90颗症状性不可逆性牙髓炎(视觉模拟量表>54)的下颌第一磨牙,随机分为三组。
  • 1C组接受1.8 mL(1支)4%阿替卡因含1:200,000肾上腺素室温注射行常规下牙槽神经阻滞。
  • 2C组接受3.6 mL(2支)同浓度阿替卡因室温注射行下牙槽神经阻滞。
  • CC组接受1.8 mL同浓度阿替卡因4°C冷 cartridge 注射行下牙槽神经阻滞。

主要发现

  • 三组在不同注射时间的疼痛水平均存在显著差异(P < .05)。
  • 2C组与CC组疼痛水平无显著差异(P > .05)。
  • 1C组与2C组疼痛水平差异显著(P < .05)。
  • 1C组与CC组疼痛水平差异显著(P < .05)。

关键数值与推荐

  • 疼痛评估采用视觉模拟量表,纳入标准为视觉模拟量表>54。
  • 统计分析采用重复测量方差分析和Bonferroni检验,显著性水平P < .05。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Achieving anesthesia in mandibular molar teeth with irreversible pulpitis has been challenging. This study aimed to compare the efficacy of precooling articaine and increasing its dosage for inferior alveolar nerve block (IANB) in the mandibular first molars with symptomatic irreversible pulpitis. METHODS: In this randomized double-blind clinical trial, 90 first mandibular molar teeth with symptomatic irreversible pulpitis (visual analog scale >54) were randomly divided into three groups and received conventional IANB injection with 1.8 mL (1 cartridge) 1C group or 3.6 mL (two cartridges) 2C group of 4% articaine with 1:200,000 epinephrine with room temperature or 1.8 ml of the same agent with 4°C temperature cold cartridge (CC) group. The patients recorded their pain during the injection and access cavity preparation, pulp chamber, and root canal entrance using a visual analog scale. Data were analyzed by repeated measure of analysis of variance and Bonferroni tests (P < .05). RESULTS: In all three groups, the pain levels at different injection times were significantly different (P < .05). The pain level did not differ significantly between the 2C group and the CC group (P > .05), but the difference was significant between the 1C group and 2C groups (P < .05) and also between the 1C group and CC group (P < .05). CONCLUSIONS: Administration of cold articaine provides a significantly higher success rate of IANBs in mandibular first molar teeth with symptomatic irreversible pulpitis compared to IANB with articaine kept at room temperature; however, increasing the dosage of articaine led to a significantly higher success rate.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Fattahi B, Ghasemi N, Shakouei S, et al. Effect of Precooling the Anesthetic Agent in Comparison to Increasing the Dosage on the Success Rate of Inferior Alveolar Nerve Block Using Articaine in Mandibular First Molars with Symptomatic Irreversible Pulpitis: A Double-Blind, Randomized, Controlled Clinical Trial. J Endod. 2025. PMID: 40447259. doi:10.1016/j.joen.2025.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。